Factors influencing prognosis after dose-intensive therapy for recurrent or refractory Hodgkin's disease. Results of sequential trials: a case for treating patients with resistant disease. Academic Article uri icon

Overview

publication date

  • December 29, 1995

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Hodgkin Disease

Identity

Scopus Document Identifier

  • 0029554342

Digital Object Identifier (DOI)

  • 10.1111/j.1749-6632.1995.tb31063.x

PubMed ID

  • 8597368

Additional Document Info

volume

  • 770